Neoplasms, Ductal, Lobular, and Medullary
"Neoplasms, Ductal, Lobular, and Medullary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, intraductally. The emphasis of the name is on the location of the neoplastic tissue rather than on its histological type. Most cancers of this type are located in the breast.
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Ductal, Lobular, and Medullary".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Ductal, Lobular, and Medullary".
- Neoplasms, Ductal, Lobular, and Medullary
- Carcinoma, Ductal
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Lobular
- Carcinoma, Medullary
- Paget Disease, Extramammary
- Papilloma, Intraductal
This graph shows the total number of publications written about "Neoplasms, Ductal, Lobular, and Medullary" by people in Harvard Catalyst Profiles by year, and whether "Neoplasms, Ductal, Lobular, and Medullary" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
Below are the most recent publications written about "Neoplasms, Ductal, Lobular, and Medullary" by people in Profiles.
-
Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study. Eur J Cancer Prev. 2010 Mar; 19(2):126-30.
-
The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases. Korean J Radiol. 2010 Mar-Apr; 11(2):178-86.
-
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Ann Oncol. 2001 Dec; 12(12):1693-8.
-
Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg. 1997 Sep; 226(3):279-86; discussion 286-7.